Advertisement
News
Advertisement

BioVex to be acquired by Amgen for up to $1 billion

Tue, 01/25/2011 - 4:37pm
Mass High Tech: The Journal of New England Technology

One of the original biotech stars, Amgen, has reached agreement to acquire Woburn-based BioVex Group Inc. for what could total $1 billion – $425 million in upfront cash and up to $575 million in additional payments based on regulatory and sales milestones.

Amgen, based in Thousand Oaks, Calif., said that the boards of both companies have approved the deal.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading